179 related articles for article (PubMed ID: 36649072)
1. Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment.
Gao Y; Hu S; Li R; Jin S; Liu F; Liu X; Li Y; Yan Y; Liu W; Gong J; Yang S; Tu P; Shen L; Bai F; Wang Y
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36649072
[TBL] [Abstract][Full Text] [Related]
2. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression.
García-Díaz N; Casar B; Alonso-Alonso R; Quevedo L; Rodríguez M; Ruso-Julve F; Esteve-Codina A; Gut M; Gru AA; González-Vela MC; Gut I; Rodriguez-Peralto JL; Varela I; Ortiz-Romero PL; Piris MA; Vaqué JP
J Invest Dermatol; 2022 May; 142(5):1391-1400.e15. PubMed ID: 34687742
[TBL] [Abstract][Full Text] [Related]
3. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.
Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C
J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872
[TBL] [Abstract][Full Text] [Related]
4. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
Kingeter LM; Schaefer BC
J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
6. PD-1 Tumor Suppressor Signaling in T Cell Lymphomas.
Wartewig T; Ruland J
Trends Immunol; 2019 May; 40(5):403-414. PubMed ID: 30979616
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
8. Annexin A5 is essential for PKCθ translocation during T-cell activation.
Hu Z; Li L; Zhu B; Huang Y; Wang X; Lin X; Li M; Xu P; Zhang X; Zhang J; Hua Z
J Biol Chem; 2020 Oct; 295(41):14214-14221. PubMed ID: 32796034
[TBL] [Abstract][Full Text] [Related]
9. Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors.
Kang DH; Chung C; Sun P; Lee DH; Lee SI; Park D; Koh JS; Kim Y; Yi HS; Lee JE
Cancer Immunol Immunother; 2022 Mar; 71(3):579-588. PubMed ID: 34278517
[TBL] [Abstract][Full Text] [Related]
10. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
11. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
Khoshnan A; Bae D; Tindell CA; Nel AE
J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
[TBL] [Abstract][Full Text] [Related]
12. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.
Ai L; Xu A; Xu J
Adv Exp Med Biol; 2020; 1248():33-59. PubMed ID: 32185706
[TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosine-dependent interaction between the kinases PKCθ and Zap70 promotes proximal TCR signaling.
Xie J; Han X; Zhao C; Canonigo-Balancio AJ; Yates JR; Li Y; Lillemeier BF; Altman A
Sci Signal; 2019 Apr; 12(577):. PubMed ID: 30992398
[TBL] [Abstract][Full Text] [Related]
14. Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis.
Ni X; Maiti S; Redko A; Bijani P; Duvic M
Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):158-168. PubMed ID: 34543492
[TBL] [Abstract][Full Text] [Related]
15. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
[TBL] [Abstract][Full Text] [Related]
16. Novel protein kinase C θ: coronin 1A complex in T lymphocytes.
Siegmund K; Thuille N; Posch N; Fresser F; Baier G
Cell Commun Signal; 2015 Mar; 13():22. PubMed ID: 25889880
[TBL] [Abstract][Full Text] [Related]
17. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
18. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
[TBL] [Abstract][Full Text] [Related]
19. Novel mutant mouse line emphasizes the importance of protein kinase C theta for CD4
Siegmund K; Thuille N; Posch N; Fresser F; Leitges M; Baier G
Cell Commun Signal; 2019 May; 17(1):56. PubMed ID: 31138259
[TBL] [Abstract][Full Text] [Related]
20. Role of CXCR3 signaling in response to anti-PD-1 therapy.
Han X; Wang Y; Sun J; Tan T; Cai X; Lin P; Tan Y; Zheng B; Wang B; Wang J; Xu L; Yu Z; Xu Q; Wu X; Gu Y
EBioMedicine; 2019 Oct; 48():169-177. PubMed ID: 31521609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
